Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

Background/Purpose: In light of the current COVID-19 pandemic, whether patients with rheumatic musculoskeletal disease (RMD) treated with conventional (cs) or biologic (b) disease-modifying drugs (DMARDs) exhibit an adequate immune response to the currently available SARS-CoV-2 vaccinations remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Karen, Graversgaard, Christine, Petersen, Randi, Jakobsen, Henning, Bojesen, Anders Bo, Krogh, Niels Steen, Glintborg, Bente, Hetland, Merete Lund, Hendricks, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777708/
https://www.ncbi.nlm.nih.gov/pubmed/35062696
http://dx.doi.org/10.3390/vaccines10010035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777708/
https://www.ncbi.nlm.nih.gov/pubmed/35062696
http://dx.doi.org/10.3390/vaccines10010035

Ejemplares similares